US5977144A
(en)
*
|
1992-08-31 |
1999-11-02 |
University Of Florida |
Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
|
US5852041A
(en)
*
|
1993-04-07 |
1998-12-22 |
Sibia Neurosciences, Inc. |
Substituted pyridines useful as modulators of acethylcholine receptors
|
US5824692A
(en)
*
|
1995-01-06 |
1998-10-20 |
Lippiello; Patrick Michael |
Pharmaceutical compositions for prevention and treatment of central nervous system disorders
|
US5731314A
(en)
*
|
1995-01-06 |
1998-03-24 |
Bencherif; Merouane |
Pharamceutical compositions for prevention and treatment of tourette's syndrome
|
US5597919A
(en)
*
|
1995-01-06 |
1997-01-28 |
Dull; Gary M. |
Pyrimidinyl or Pyridinyl alkenyl amine compounds
|
DE69535131T2
(de)
*
|
1995-01-06 |
2007-03-01 |
Targacept, Inc. |
Pharmazeutische zusammensetzungen zur vorbeugung und behandlung von störungen des zentralnervensystems
|
US5616707A
(en)
*
|
1995-01-06 |
1997-04-01 |
Crooks; Peter A. |
Compounds which are useful for prevention and treatment of central nervous system disorders
|
US5585388A
(en)
*
|
1995-04-07 |
1996-12-17 |
Sibia Neurosciences, Inc. |
Substituted pyridines useful as modulators of acetylcholine receptors
|
US6194581B1
(en)
|
1995-04-07 |
2001-02-27 |
Merck & Co., Inc. |
Substituted pyridines useful as modulators of acetylcholine receptors
|
US5583140A
(en)
*
|
1995-05-17 |
1996-12-10 |
Bencherif; Merouane |
Pharmaceutical compositions for the treatment of central nervous system disorders
|
US5794887A
(en)
|
1995-11-17 |
1998-08-18 |
Komerath; Narayanan M. |
Stagnation point vortex controller
|
US5616716A
(en)
*
|
1996-01-06 |
1997-04-01 |
Dull; Gary M. |
(3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
|
US5663356A
(en)
*
|
1996-04-23 |
1997-09-02 |
Ruecroft; Graham |
Method for preparation of aryl substituted alefinic secondary amino compounds
|
US6979695B2
(en)
*
|
1996-04-23 |
2005-12-27 |
Targacept, Inc. |
Compounds capable of activating cholinergic receptors
|
US6166048A
(en)
|
1999-04-20 |
2000-12-26 |
Targacept, Inc. |
Pharmaceutical compositions for inhibition of cytokine production and secretion
|
US20020052497A1
(en)
*
|
2000-03-09 |
2002-05-02 |
Targacept, Inc. |
Compounds capable of activating cholinergic receptors
|
BR9708815B1
(pt)
|
1996-04-23 |
2009-01-13 |
|
compostos úteis para prevenção e tratamento de desordens do sistema nervoso central.
|
US6531606B1
(en)
*
|
1997-02-21 |
2003-03-11 |
Targacept, Inc. |
Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
|
US5811442A
(en)
*
|
1997-02-21 |
1998-09-22 |
Bencherif; Merouane |
Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow
|
US5861423A
(en)
*
|
1997-02-21 |
1999-01-19 |
Caldwell; William Scott |
Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
|
US7214686B2
(en)
*
|
1997-06-30 |
2007-05-08 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
BR9908190A
(pt)
*
|
1998-02-24 |
2000-10-24 |
Univ Wake Forest |
Processos para tratar a dor especìfica de fêmea em um paciente fêmea, e para tratar a dor crÈnica em um paciente
|
EP1068186A2
(en)
|
1998-04-02 |
2001-01-17 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
US6232316B1
(en)
|
1998-06-16 |
2001-05-15 |
Targacept, Inc. |
Methods for treatment of CNS disorders
|
US7790757B2
(en)
*
|
1998-06-16 |
2010-09-07 |
Targacept, Inc. |
Compounds capable of activating cholinergic receptors
|
US20050131034A1
(en)
*
|
1998-06-16 |
2005-06-16 |
Caldwell William S. |
Compounds capable of activating cholinergic receptors
|
US6218383B1
(en)
|
1998-08-07 |
2001-04-17 |
Targacept, Inc. |
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
|
US6262124B1
(en)
|
1998-10-22 |
2001-07-17 |
Gary Maurice Dull |
Pharmaceutical compositions and methods for use
|
US6953855B2
(en)
*
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US6432975B1
(en)
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
US20010031771A1
(en)
|
1999-05-24 |
2001-10-18 |
Gary Maurice Dull |
Pharmaceutical compositions and methods for use
|
AU5326100A
(en)
*
|
1999-06-07 |
2000-12-28 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
US6455554B1
(en)
|
1999-06-07 |
2002-09-24 |
Targacept, Inc. |
Oxopyridinyl pharmaceutical compositions and methods for use
|
US6890935B2
(en)
*
|
1999-11-01 |
2005-05-10 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
FR2810886B1
(fr)
*
|
2000-06-05 |
2002-12-27 |
Sanjuan Benito Arranz |
Dans le traitement des maladies neurodegeneratives : (notamment alzheimer et parkinson), utilisation pour un medicament : de la nicotine et du sildenafil (ou des derives des deux)
|
US6852741B2
(en)
|
2001-12-31 |
2005-02-08 |
University Of Florida |
Compositions and methods for treatment of neurological disorders
|
CA2494506C
(en)
*
|
2002-08-02 |
2009-02-10 |
Nutraceutical Development Corporation |
Development of muscle mass in a mammal
|
JP2007533641A
(ja)
*
|
2003-10-15 |
2007-11-22 |
ターガセプト,インコーポレイテッド |
疼痛緩和および中枢神経系障害治療のためのアザビシクロ化合物
|
CA2563023C
(en)
*
|
2004-04-02 |
2012-01-24 |
Arterial Remodelling Technologies, Inc. |
Polymer-based stent assembly
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
JP5254616B2
(ja)
|
2004-09-13 |
2013-08-07 |
クロノ セラピューティクス、インコーポレイテッド |
生物学的同調性(biosynchronous)経皮的薬物送達
|
UA88792C2
(ru)
*
|
2004-11-10 |
2009-11-25 |
Таргасепт, Інк. |
Гидроксибензоатные соли метаникотиновых соединений
|
US7459469B2
(en)
|
2004-11-10 |
2008-12-02 |
Targacept, Inc. |
Hydroxybenzoate salts of metanicotine compounds
|
TWI389889B
(zh)
*
|
2006-05-09 |
2013-03-21 |
Targacept Inc |
(2s)-(4e)-n-甲基-5-〔3-(5-異丙氧基吡啶)基〕-4-戊烯-2-胺之新穎多晶型
|
WO2007134038A2
(en)
*
|
2006-05-09 |
2007-11-22 |
Astrazeneca Ab |
Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
|
WO2008034041A2
(en)
*
|
2006-09-15 |
2008-03-20 |
Astrazeneca Ab |
Therapeutic combinations
|
US20100028447A1
(en)
*
|
2007-01-22 |
2010-02-04 |
Targacept, Inc. |
Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
|
WO2008122049A2
(en)
*
|
2007-04-02 |
2008-10-09 |
Parkinson's Institute |
Methods and compositions for reduction of side effects of therapeutic treatments
|
CA2695214A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Targacept, Inc. |
Transdermal administration of (2s)-(4e)-n-methyl-5-(3-(5-is0pr0p0xypyridin)yl)-4-penten-2-amine
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
US8703802B2
(en)
|
2010-05-20 |
2014-04-22 |
Targacept, Inc. |
Process for the preparation of aryl substituted olefinic amines
|
CA2841785A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
US11219627B2
(en)
*
|
2014-05-16 |
2022-01-11 |
Synaptec Development Llc |
Clearance of amyloid beta
|
EP3250258A4
(en)
|
2015-01-28 |
2018-09-05 |
Chrono Therapeutics, Inc. |
Drug delivery methods and systems
|
AU2016228779A1
(en)
|
2015-03-12 |
2017-09-07 |
Chrono Therapeutics Inc. |
Craving input and support system
|
US9724340B2
(en)
|
2015-07-31 |
2017-08-08 |
Attenua, Inc. |
Antitussive compositions and methods
|
JP2020503950A
(ja)
|
2017-01-06 |
2020-02-06 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
経皮薬剤送達の装置及び方法
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|